Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19)

Authors
Category Primary study
Year 2020
INTERVENTION: experimental group 1:Hydroxychloroquine 0.1 oral 2/ day;experimental group 2:Hydroxychloroquine 0.2 oral 2/ day;Placebo control group:Starch pill oral 2/ day; CONDITION: novel coronavirus pneumonia (COVID‐19) PRIMARY OUTCOME: The time when the nucleic acid of the novel coronavirus turns negative;T cell recovery time; INCLUSION CRITERIA: Patients with novel coronavirus pneumonia who agreed to participate in this trial and signed the informed consent form.
Epistemonikos ID: 9bcb3c4dcdde6853081d8116e23176f0b379b47c
First added on: Mar 31, 2020